Recent advancement in the field of anticonvulsants: A review

Letters in Drug Design and Discovery

Volumn 7, Issue 9, 2010, Pages 694-706

  Pandey, Shailendra ^a   Srivastava, Radhey Shyam ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

Anticonvulsant agent; Epilepsy; Maximal electroshock seizure; Pentylenetetrazole

Indexed keywords

1 PHENYLPIPERAZINE; 3 CHLORO 2 METHYLPHENYL; 4 AMINOBENZANILIDE DERIVATIVE; 4 HYDROXYBUTYRIC ACID; ACETAZOLAMIDE; AMIDE; AMINO ACID DERIVATIVE; ANTICONVULSIVE AGENT; CAPROLACTAM; CARBONATE DEHYDRATASE INHIBITOR; INDOLE DERIVATIVE; ISOINDOLINEDIONE DERIVATIVE; ISOINDOLINONE; ISOTRYPTAMINE DERIVATIVE; LACTAM; METHAZOLAMIDE; QUINAZOLIN 4(3H) ONE DERIVATIVE; QUINAZOLINE DERIVATIVE; QUINAZOLINONE DERIVATIVE; SEMICARBAZONE; SEMICARBAZONE DERIVATIVE; SEROTONIN; TETRAHYDROISOQUINOLINE; TOPIRAMATE; TRYPTAMINE; TRYPTAMINE DERIVATIVE; UNCLASSIFIED DRUG; ZONISAMIDE;

ANTICONVULSANT ACTIVITY; ARTICLE; DRUG DESIGN; DRUG MECHANISM; DRUG STRUCTURE; DRUG TOLERABILITY; EPILEPSY; HUMAN; NONHUMAN; PHARMACOPHORE; PRIORITY JOURNAL;

EID: 77958505561     PISSN: 15701808     EISSN: None     Source Type: Journal    
DOI: 10.2174/157018010792929487     Document Type: Article

References (109)

1. Prinz, A.A. In Understanding epilepsy through network modeling, Proceedings of the National Academy of Sciences, USA, 2008; 105(16), pp. 5953-5954.
2. Swann, A.C. Major system toxicities and side effects of anticonvulsants. J. Clin. Psychiatry, 2001, 62(14), 16-21.
3. Pack, A.M.; Morrell, M.J. Adverse effects of antiepileptic drugs on bone structure: Epidemiology, mechanisms and therapeutic implications. CNS Drugs, 2001, 15(8), 633-642(10).
4. Richens, A.; Perucca, E. In Clinical pharmacology and medical treatment; Laidlaw J, Richens A, Chadwick D, Ed.; A Textbook of Epilepsy. Churchill Livingston: Edinburgh, 1993; pp. 495-559.
5. Macdonald, R.L.; McLean, M.J. Anticonvulsant drugs: Mechanisms of action. Adv. Neurol, 1986, 44, 713-736.
6. Czapiński, P.; Blaszczyk, B.; Czuczwar, S.J. Mechanisms of action of antiepileptic drugs. Curr. Top. Med. Chem., 2005, 5, 3-14.
7. Macdonald, R.L.; Kelly, K.M. Antiepilaptic drug mechanism of action. Epilapsia, 1995, 36, S2-S12.
8. Deckers, C.L.P.; Czuczwar, S.J.; Hekster, Y.A.; Keyser, A.; Kubova, H.; Meinardi, H.; Patsalos, P.; Renier, W.O.; Van Rijn, CM. Selection of antiepileptic drug polytherapy based on mechanism of action: The evidence reviewed. Epilepsia, 2000, 41, 1364-1374.
9. Loscher, W.; Schmidt, D. Strategies in antiepileptic drug development: Is rational drug design superior to random drug screening and structural variation? Epilepsy Res., 1994, 17, 95-134.
10. Brunbech, L.; Sabers, A. Effect of antiepileptic drugs on cognitive function in individuals with epilepsy: A comparative review of newer versus older agents. Drugs, 2002, 62(4), 593-604.
11. Löscher, W.; Schmidt, D. New horizons in the development of antiepileptic drugs: Innovative strategies. Epilepsy Res., 2006, 69(3), 183-272.
12. Dailey, J.W.; Mishra, P.K.; Ko, K.H.; Penny, J.E.; Jobe, P.C. Serotonergic abnormalities in the central nervous system of seizure-naive genetically epilepsy-prone rats. Life Sci., 1992, 50, 319-326.
13. Yan, Q.S.; Jobe, P.C; Cheong, J.H.; Ko, K.H.; Dailey, J.W. Role of serotonin in the anticonvulsant effect of fluoxetine in genetically epilepsy-prone rats. Naunyn-Schmiedebergs Arch. Pharmacol, 1994, 350, 149-152.
14. Bonnycastle, D.D.; Giarman, N.J.; Paasonen, M.K. Anticonvulsant compounds and 5-hydroxytryptamine in rat brain. Br. J. Pharmacol, 1957, 12, 228-231.
15. Gyorgy, B.; Valeria, K.; Pal, R.; Rita, J. Serotonin and epilepsy. J. Neurochem., 2007, 100, 857-873.
16. Jakus, R.; Graf, M.; Juhasz, G.; Gerber, K.; Levay, G.; Halasz, P.; Bagdy, G. 5-HT2C Receptors inhibit and 5-HT1A receptors activate the generation of spike-wave discharges in a genetic rat model of absence epilepsy. Exp. Neurol, 2003, 184, 964-972.
17. Filakovszky, J.; Gerber, K.; Bagdy, G. A serotonin-1A receptor agonist and N-methyl-D-aspartate receptor antagonist oppose each other's effects in a genetic rat epilepsy model. Neurosci. Lett., 1999, 261, 89-92.
18. Filakovszky, J.; Kantor, S.; Halasz, P.; Bagdy, G. 8-OH-DPAT and MK-801 affect epileptic activity independently of vigilance. Neurochem. Int., 2001, 38, 551-556.
19. Bishop, M.J; Nilsson, B.M. New 5-HT2C receptor agonist. Exp. Opin. Ther. Patent, 2003, 13, 1691-1705.
20. Kimura, Y.; Hatanaka, K.; Naitou, Y.; Maeno, K.; Shimada, I.; Koakutsu, A.; Wanibuchi, F.; Yamaguchi, T. Pharmacological profile of YM348, A novel, potent and orally active 5-HT2C receptor agonist. Eur. J. Pharmacol, 2004, 483, 37-43.
21. + ion channels. Br. J. Pharmacol, 2003, 140, 1331-1339.
22. Isaac, M. Serotonergic 5-HT2C receptors as a potential therapeutic target for the design antiepileptic drugs. Curr. Top. Med. Chem., 2005, 5, 59-67.
23. Obniska, J.; Kolaczkowski, M.; Bojarski, A.J.; Duszyhska, B. Synthesis, anticonvulsant activity and 5-HT1A, 5-HT2A receptor affinity of new N-[(4-arylpiperazin-1-yl)-alkyl] derivatives of 2-azaspiro [4.4] nonane and [4.5] decane-1, 3-dione. Eur. J. Med. Chem., 2006, 41(7), 874-881.
24. Obniska, J.; Zagorska, A. Synthesis and anticonvulsant properties of new N-[(4-arylpiperazin-1-yl)-methyl] derivatives of 3-aryl pyrrolidine-2,5-dione and 2-aza-spiro[4.4]nonane-1,3-dione. IlFarmaco, 2003, 58(12), 1227-1234.
25. Oliveira, F.A.; Silva, D.A.; Quintans-Junior, L.J.; Gutierrez, S.J.C; Almeida, R.N.; Barbosa-Filho, J.M.; Souza, M.F.V. Synthesis and structural characterization of N-benzoyl-tryptamine and its new analogue N-salicyloyltryptamine, A potential anticonvulsant agent. J. Chil Chem. Soc, 2006, 51(2), 919-922.
26. Clark, C.R.; McMillian, C.L. Comparative anticonvulsant activity of 4-chlorobenzene sulfonamide and prototype antiepileptic drugs in rodents. Epilepsia, 1990, 31(4), 474-479.
27. Akgul, O.; Kilic, F.S.; Erol, K.; Pabuccuoglu, V. Synthesis and anticonvulsant activity of some N-phenyl-2-phtalimidoethanesulfonamide derivatives. Arch. Pharm., 2007, 340(12), 656-660.
28. Flaherty, A.P.T.; Greenwood, T.D.; Manheim, A.L.; Wolfe, J.F. Synthesis and evaluation of N-(phenylacetyl) trifluoromethane sulfonamides as anticonvulsant. J. Med. Chem., 1996, 39, 1509-1513.
29. Siddiqui, N.; Pandeya, S.N.; Khan, S.A.; Stables, J.P.; Rana, A.; Alam, M.; MD. Arshada,; Bhata, M.A. Synthesis and anticonvulsant activity of sulfonamide derivatives-hydrophobic domain. Bioorg. Med. Chem. Lett, 2007, 17, 255-259.
30. Ilies, M.A.; Masereel, B.; Rolin, S.; Scozzafava, A.; Câmpeanu, G.; Cîmpeanu, V.; Supuran, C.T. Carbonic anhydrase inhibitors: Aromatic and heterocyclic sulfonamides incorporating adamantyl moieties with strong anticonvulsant activity. Bioorg. Med. Chem., 2004, 12(10), 2717-2726.
31. Hen, N.; Bialer, M.; Wlodarczyk, B.; Finnell, R.H.; Yagen, B. Syntheses and evaluation of anticonvulsant profile and teratogenicity of novel amide derivatives of branched aliphatic carboxylic acids with 4-aminobenzensulfonamide. J. Med. Chem., 2010, 53, 4177-4186.
32. Sarro, G.D.; Gratteri, S.; Bonacci, F.; Musumeci, S.A.; Elia, M.; Sarro, A.D. Topiramate potentiates the antiseizure activity of some anticonvulsants in DBA/2 mice. Eur. J. Pharmacol, 2000, 388(2), 163-170.
33. Borowicz, K.K.; Luszczki, J.J.; Duda, A.M.; Czuczwar, S.J. Effect of topiramate on the anticonvulsant activity of conventional antiepileptic drugs in two models of experimental epilepsy. Epilepsia, 2003, 44(5), 640-646.
34. Kawasaki, H.; Tancredi, V.; D'Arcangelo, G.; Avoli, M. Multiple actions of the novel anticonvulsant drug topiramate in the rat subiculum In-vitro. Brain Res., 1998, 807, 125-134.
35. Masereel, B.; Rolin, S.; Abbate, F.; Scozzafava, A.; Supuran, C.T. Carbonic anhydrase inhibitors: Anticonvulsant sulfonamides incorporating valproyl and other lipophilic moieties. J. Med. Chem., 2002, 45, 312-320.
36. Paruszewski, R.; Strupinska, M.; Stables, J. P.; Swiader, M.; Czuczwar, S.; Kleinrok, Z.; Turski, W. Amino acid derivatives with anticonvulsant activity. Chem. Pharm. Bull, 2001, 49(5), 629-631.
37. Conley, J.D.; Kohn, H. Functionalized DL-amino acid derivatives. Potent new agents for the treatment of epilepsy. J. Med. Chem., 1987, 30, 567-574.
38. Kohn, H.; Conley, J.D.; Leander, J.D. Marked stereo specificity in a new class of anticonvulsants. Brain Res., 1988, 457, 371-375.
39. Kohn, H.; Sawhney, K.N.; LeGall, P.; Conley, J.D.; Robertson, D.W.; Leander, J.D. Preparation and anticonvulsant activity of a series of functionalized a-aromatic and α-heteroaromatic amino acids. J. Med. Chem., 1990, 33, 919-926.
40. Kohn, H.; Sawhney, K.N.; LeGall, P.; Robertson, D.W.; Leander, J.D. Preparation and anticonvulsant activity of a series of functionalized a-heteroaromatic-substituted amino acids. J. Med. Chem., 1991, 34, 2444-2452.
41. Kohn, H.; Sawhney, K.H.; Bardel, P.; Robertson, D.W.; Leander, J.D. Synthesis and anticonvulsant activities of α-heteroaromatic- α-acetamido-N-benzylacetamide derivatives. J. Med. Chem., 1993, 36, 3350-3360.
42. Bardel, P.; Bolanos, A.; Kohn, H. Synthesis and anticonvulsant activities of a-acetamido-N-benzylacetamide derivatives containing an electron-deficient a-heteroaromatic substituent. J. Med. Chem., 1994, 37, 4567-4571.
43. Kohn, H.; Sawhney, K.N.; Robertson, D.W.; Leander, J.D. Anticonvulsant properties of N-substituted α, α-diamino acid derivatives. J. Pharm. Sci., 1994, 83, 689-691.
44. Choi, D.; Stables, J.P.; Kohn, H. Synthesis and anticonvulsant activities of N-benzyl-2-acetamidopropionamide derivatives. J. Med. Chem., 1996, 39, 1907-1916.
45. Andurkar, S.V.; Stables J.P.; Kohn, H. The anticonvulsant activities of N-benzyl-3-methoxypropionamides. Bioorg. Med. Chem., 1999, 7, 2381-2389.
46. Le Tiran, A.; Stables, J.P.; Kohn, H. Functionalized amino acid anticonvulsants: Synthesis and pharmacological evaluation of conformationally restricted analogues. Bioorg. Med. Chem., 2001, 9, 2693-2708.
47. Andurkar, S.V.; Béguin, C; Stables, J.P.; Kohn, H. Synthesis and structural studies of aza analogues of funcionalized amino acids: New anticonvulsant agents. J. Med. Chem., 2001, 44, 1475-1478.
48. Salomé, C; Salomé-Grosjean, E.; Park, K.D.; Morieux, P.; Swendiman, R.; DeMarco, E.; Stables, J.P.; Kohn, H. Synthesis and anticonvulsant activities of (R)-N-(4'-substituted) benzyl 2-acetamido-3-methoxypropionamides. J. Med. Chem., 2010, 11, 53(3), 1288-1305.
49. Le Tiran, A.; Stables, J.P.; Kohn, H. Design and evaluation of affinity labels of functionalized amino acid anticonvulsants. J. Med. Chem., 2002, 45, 4762-4773.
50. Shen, M.; Le Tiran, A.; Xiao, Y.; Golbraikh, A.; Kohn, H.; Trop-sha, A. Quantitative structure-activity relationships analysis of functionalized amino acid anticonvulsant agents using K nearest neighbor and simulated annealing PLS methods. J. Med. Chem., 2002, 45, 2811-2823.
51. Béguin, C; Andurkar, S.V.; Jin, A.Y.; Stables, J.P.; Weaver, D.F.; Kohn, H. Functionalized amido ketones: New anticonvulsant agents. Bioorg. Med. Chem., 2003, 11, 4275-4285.
52. Béguin, C; Le Tiran, A.; Stables, J.P.; Voyksner, R.D.; Kohn, H. N-Substituted amino acid N'-benzylamides: Synthesis, anticonvulsant, and metabolic activities. Bioorg. Med. Chem., 2004, 12, 3079-3096.
53. Paruszewski, R.; Rostafińska-Suchar, G.; Strupińska, M.; Jawor-ski, P.; Stables, J.P. Synthesis and anticonvulsant activity of some amino amide derivatives. Part 1: Alanine derivatives. Pharmazie, 1996, 51, 145-148.
54. Paruszewski, R.; Rostafińska-Suchar, G.; Strupińska, M.; Jawor-ski, P.; Winiecka, I.; Stables, J.P. Synthesis and anticonvulsant activity of some amino amide derivatives. Part 2: Derivatives of Gly, Ala, Leu, Pro, Trp, Phe (4Cl), Ala (a-Me). Pharmazie, 1996, 51, 212-215.
55. Paruszewski, R.; Rostafińska-Suchar, G.; Strupińska, M.; Winiecka, I.; Stables, J.P. Synthesis and anticonvulsant activity of some amino amide derivatives. Part 3: Derivatives of Ala. Arg, Tzl, Gly and cAbu. Pharmazie, 2000, 55, 27-30.
56. Paruszewski, R.; Strupińska, M.; Rostafińska-Suchar, G.; Stables, J.P. Anticonvulsant activity of benzyl amides of some amino acids and heterocyclic acids. Protein Pept. Lett., 2003, 10, 475-482.
57. Paruszewski, R.; Rostafińska-Suchar, G.; Strupińska, M.; Stables, J.P. In The Fourth Multidisciplinary Conferences on Drug Research, Gdańsk-Sobieszewo, Book of abstract, 2004; p-129.
58. Kieć-Kononowicz, K.; Karolak-Wojciechowska, J.; Handzlik, J. Glycine derivatives of imidazolones as potential ligands of glycine binding site of NMDA receptors. Acta Pol. Pharm.-Drug Res., 1998, 55, 381-388.
59. Kieć-Kononowicz, K.; Karolak-Wojciechowska, J. Structure and activity studies on glycine receptor ligands. Diphenyl imidazolin-4-one glycinamides. Acta Pol. Pharm.- Drug Res., 1998, 55, 389-397.
60. Karolak-Wojciechowska, J.; Kieć-Kononowicz, K.; Mrozek, A. Structure and activity studies of glycine receptor ligands. Structural remarks on arylidene-imidazoline-4-one glycinates and glycinamides. J. Mol. Srtuct., 2001, 597, 73-81.
61. Karolak-Wojciechowska, J.; Mrozek, A.; Kieć-Kononowicz, K.; Handzlik, J. Structure and activity studies of glycine receptor ligands. Arylidene-imidazoline-4-one amino acids. J. Mol. Srtuct., 2003, 649, 25-36.
62. Tan, C.Y.K.; Wainman, D.; Weaver, D.F. N-, α-, and β-Substituted 3-aminopropionic acids: Design, syntheses and antiseizure activities. Bioorg. Med. Chem., 2003, 11, 113-121.
63. Monem, A.A.; Hafez, A. Synthesis and anticonvulsant evaluation of N-substituted-isoindolinedione derivatives. Arch. Pharm. Res., 2004, 27(5), 495-501.
64. Kamihski, K.; Obniska, J. Design synthesis, and anticonvulsant activity of N-phenylamino derivatives of 3,3-dialkyl-pyrrolidine-2,5-diones and hexahydro-isoindole-1,3-diones. Bioorg. Med. Chem., 2008, 16(9), 4921-4931.
65. Klunk, W.E.; McKeon, A.C.; Covey, D.F.; Ferrendelli, J.A. α-Substituted y-Butyrolactones: New class of anticonvulsant drugs. Science, 1982, 217, 1040-1042.
66. Klunk, W.E.; Covey, D.F.; Ferrendelli, J.A. Anticonvulsant properties of α-, γ-, and α-γ-substituted γ-butyrolactones. Mol. Pharmacol, 1982, 22, 438-443.
67. Albert, J.R.; Boxill, G.C.; Weikel, J. H. Jr. Anticonvulsant and toxicologic properties of some benzilic amides and the physiological disposition of the N-ethyl derivative. J. Pharmacol. Exp. Ther., 1961, 131, 85-90.
68. Obniska, J.; Zejc, A. Synthesis, physicochemical and anticonvulsant properties of some N-substituted amides of 3-spirocycloalkylpyrrolidine-2,5-dione. Acta. Pol. Pharm., 2003, 60(5), 383-390.
69. Tasso, S.M.; Moon, S.C.; Bruno-Blanch, L.E.; Estiu, G.L. Characterization of the anticonvulsant profile of valpromide derivatives. Bioorg. Med. Chem., 2004, 12, 3857-3869.
70. Clark, C.R.; Sansom, R.T.; Lin, CM.; Norris, G.N. Anticonvulsant activity of some 4-aminobenzanilides. J. Med. Chem., 1985, 28, 1259-1262.
71. Brouillettet, W.J.; Grunewald, G.L. Synthesis and anticonvulsant activity of some substituted lactams and amides. J. Med. Chem., 1984, 27, 202-206.
72. Hill, M.W.; De la Cruz, M.A.M.; Covey, D.F.; Rothman, S.M. Effects of anticonvulsant lactams on in-vitro seizures in the hippocampal slice preparation. Epilepsy Res., 1999, 37, 121-131.
73. Potschka, H.; Feuerstein, T.J.; Löscher, W. Gabapentin-lactam, A close analogue of the anticonvulsant gabapentin, exerts convulsant activity in amygdala kindled rats. Arch. Pharmacol, 2000, 361, 200-205.
74. Jones, P. J.; Merrick, E.C.; Batts, T.W.; Hargus, N.J.; Wang, Y.; Stables, J.P.; Bertram, E.H.; Brown, M.L.; Patel, M.K. Modulation of sodium channel inactivation gating by a novel lactam: Implications for seizure suppression in chronic limbic epilepsy. J. Pharmacol. Exp. Ther., 2009, 328, 201-212.
75. Reddy, P.A.; Woodward, K.E.; McIlheran, S.M.; Hsiang, B.C.H.; Latifi, T. N.; Hill, M.W.; Rothman, S.M.; Ferrendelli, J.A.; Covey, D.F. Synthesis and anticonvulsant activities of 3,3-dialkyl and 3-alkyl-3-benzyl-2-piperidinones (S-Valerolactams) and hexahydro-2H-azepin-2-ones (£-Caprolactams). J. Med. Chem., 1997, 40, 44-49.
76. Grimm, J.B.; Stables, J.P.; Brown, M.L. Design, synthesis, and development of novel caprolactam anticonvulsants. Bioorg. Med. Chem., 2003, 11, 4133-4141.
77. Georgey, H.; Gawad, N.A.; Abbas, S. Synthesis and anticonvulsant activity of some quinazolin-4-(3H)-one derivatives. Molecules, 2008, 13, 2557-2569.
78. Wolfe, J.F.; Rathman, T.L.; Sleevi, M.C.; Campbell, J.A.; Greenwood, T.D. Synthesis and anticonvulsant activity of some new 2-substituted 3-aryl-4(3H)-quinazolinones. J. Med. Chem., 1990, 33, 161-166.
79. Vaidya, N.A.; Panos, C.H.; Kite, A.; Iturrian W.B.; Blanton, DeWitt. C. Synthesis of 3,4-dihydro-4-oxoquinazolin derivatives as potential anticonvulsants. J. Med. Chem., 1983, 26, 1422-1425.
80. Archana Srivastava, V.K, Kumar, A. Synthesis of newer thiadiazolyl and thiazolidinonyl quinazolin-4(3H) - ones as potential anticonvulsant agents. Eur. J. Med. Chem., 2002, 37, 873-882.
81. El-Helby, A.G.; Wahab, M.H. Design and synthesis of some new derivatives of 3H-quinazolin-4-one with promising anticonvulsant activity. Acta. Pharm., 2003, 53(2), 127-138.
82. Bajaj, K.; Srivastava, V.K.; Kumar, A. Newer substituted benzoxazepinyl-quinazolinones as potent antipsychotic and anticonvulsant agents. Arzneimittelforschung, 2003, 53(7), 480-485.
83. Waszkielewicz, A.; Bojarski, J. γ-Hydroxybutyric acid (GHB) and its chemical modifications: A review of the GHBergic system. Pol. J. Pharmacol, 2004, 56, 43-49.
84. Malawska, B.; Gobaille, S. Synthesis, physicochemical and pharmacological properties of new N-substituted amides of α-piperazine-γ-hydroxybutyric acid. Pharmazie, 1995, 50, 390-393.
85. Malawska, B.; Zejc, A. Search for new anticonvulsant compounds, Part 1: Synthesis, physicochemical and anticonvulsant properties of new derivatives of a-amino-y--phthalimidobutyric acid. Pharmazie, 1995, 50, 722-755.
86. Mendyk, A.; Salat, K.; Librowski, T.; Czarnecki, T.; Malawska, B. Influence of new γ-aminobutyric acid amide derivatives and its phthalimide precursors on the central nervous system activity in mice. Pol. J. Pharmacol, 2001, 53, 689-693.
87. Malawska, B.; Kulig, K.; Ciechanowicz-Rutkowska, M. Search for new anticonvulsant compounds, Part 2: Structure-activity relationship studies of new N-substituted amides of α-piperazine-y-hydroxybutyric acid as active anticonvulsants. Arch. Pharm., 1997, 330, 91-99.
88. Malawska, B.; Antkiewicz-Michaluk, L. Search for new anticonvulsant compounds, Part 3. Synthesis, physicochemical properties, anticonvulsant activities and voltage-sensitive calcium channels affinity of N-substituted amides of a-(4-phenylpiperazine)-GABA. Pharmazie, 1999, 54, 239-243.
89. Malawska, B.; Kulig, K.; Antkiewicz-Michaluk, L.; Cliffe, I.; Porter, R.; Misra, A. Anticonvulsant activities and voltage-sensitive calcium channels receptor affinity of substituted N-benzylamides of y-amino- and γ-hydroxybutyric acid. Arch. Pharm., 1999, 332(5), 167-174.
90. Salat, K.; Mendyk, A.; Librowski, T.; Czarnecki, R.; Malawska, B. Influence of new γ-hydroxybutyric acid amide analogues on the central nervous system activity in mice. Pol. J. Pharmacol, 2002, 54, 731-736.
91. Malawska, B.; Kulig, K.; Bendieck, E. Comparison of chromatographically determined values of the lipophilicity of anticonvulsant active N-substituted amides of a-arylalkylamine-γ-hydroxybutyric acid with values estimated by computational methods. J. Planar Chromatogr., 2003, 16, 390-395.
92. Malawska, B. Searching of γ-amino- and γ-hydroxybutyric acid analogues with expected anticonvulsant activity. (Polish). Wiad. Chem., 2001, 55, 377-402.
93. Malawska, B.; Kulig, k.; Gajda, J.; Szczeblewski, D.; Musial, A.; Wieckowski, K.; Maciag D.; Stables, J. P. Design, synthesis and pharmacological evaluation of α-substituted N-benzylamides of β-hydroxybutyric acid with potential GABA-ergic activity, Part 6: Search for new anticonvulsant compounds. Acta Pol. Pharm. -Drug Res., 2007, 64(2), 127-137.
94. Malawska, B.; Kulig, K.; piewak, A.; Stables, J.P. Investigation into new anticonvulsant derivatives of a-substituted N-benzylamides of -hydroxy- and γ-acetoxybutyric acid, Part 5: Search for new anticonvulsant compounds. Bioorg. Med. Chem., 2004, 12, 625-632.
95. Dimmock, J.R.; Sidhu, K.K.; Tumber, S.D.; Basran, S.K.; Chen, M.; Quail, J.W.; Yang, J.; Rozas, I.; Weaver, D.F. Some aryl semicarbazones possessing anticonvulsant activities. Eur. J. Med. Chem., 1995, 30, 287-301.
96. Dimmock, J.R.; Pandeya, S.N.; Quail, J.W.; Pugazhenthi, U.; Allen, T.M.; Kao, G.Y.; Balzarini, J.; DeClercq, E. Evaluation of the semicarbazones, thiosemicarbazones and bis-carbohydrazones of some aryl alicyclic ketones for anticonvulsant and other biological properties. Eur. J. Med. Chem., 1995, 30, 303-314.
97. Dimmock, J.R.; Puthucode, R.N.; Smith, J.M.; Hetherington, M.; Quail, J.W.; Pugazhenthi, U.; Lecher, T.; Stables, J.P. (Aryloxy)aryl semicarbazones and related compounds: A novel class of anticonvulsant agents possessing high activity in the maximal electroshock screen. J. Med. Chem., 1996, 39, 3984-3997.
98. Puthucode, R.; Pugazhenthi, U.; Quail, J.W.; Stables, J.P.; Dimmock, J.R. Anticonvulsant activity of various aryl, arylidene and aryloxyaryl semicarbazones. Eur. J. Med. Chem., 1998, 33, 595-607.
99. Pandeya, S.N.; Ponnilavarasan, I.; Pandey, A.; Lakhan, R.; Stables, J.P. Evaluation of p-nitrophenyl substituted semicarbazones for anticonvulsant properties. Pharmazie, 1999, 54, 923-925.
100. Dimmock, J.R.; Vashishtha, S.C.; Stables, J.P. Anticonvulsant properties of various acetylhydrazones, oxamoylhydrazones and semicarbazones derived from aromatic and unsaturated carbonyl compounds. Eur. J. Med. Chem., 2000, 35, 241-248.
101. Pandeya, S.N.; Yogeeswari, P.; Stables, J.P. Synthesis and anticonvulsant activity of 4-bromophenyl substituted aryl semicarbazones. Eur. J. Med. Chem., 2000, 35, 879-886.
102. Pandeya, S.N.; Mishra, V.; Ponnilavarasan, I.; Stables, J.P. Anticonvulsant activity of p-chlorophenyl substituted aryl semicarbazones: The role of primary terminal amino group. Pol. J. Pharmacol., 2000, 52, 283-290.
103. Dimmock, J.R.; Vashishtha, S.C.; Stables, J.P. Ureylene anticonvulsants and related compounds. Pharmazie, 2000, 55, 490-494.
104. Pandeya, S.N.; Manjula, H.; Stables, J.P. Design of semicarbazones and their bio-isosteric analogues as potential anticonvulsants. Pharmazie, 2001, 56, 121-124.
105. Yogeeswari, P.; Sriram, D.; Sunil Jit, L.R.; Kumar, S.S.; Stables, J.P. Anticonvulsant and neurotoxicity evaluation of some 6-chlorobenzothiazolyl-2-thiosemicarbazones. Eur. J. Med. Chem., 2002, 37, 231-236.
106. Pandeya, S.N.; Agarwal, A.K.; Singh, A.; Stables, J.P. Design and synthesis of semicarbazones and their bio-isosteric analogues as potent anticonvulsants: The role of hydrogen bonging. Acta Pharm., 2003, 53, 15-24.
107. 4-phthalimido phenyl (thio) semicarbazides. Eur. J. Pharm. Sci., 2003, 20 341-346.
108. Yogeeswari, P.; Thirumurugan, R.; Kavya, R.; Samuel, J.S.; Stables, J.P.; Sriram, D. 3-Chloro-2-methylphenyl-substituted semicarbazones: Synthesis and anticonvulsant activity. Eur. J. Med. Chem., 2004, 39, 729-34.
109. Thirumurugan, R.; Sriram, D.; Saxena, A.; Stables, J.P.; Yogeeswari, P. 2,4-Dimethoxyphenylsemicarbazones with anticonvulsant activity against three animal models of seizures: Synthesis and pharmacological evaluation. Bioorg. Med. Chem., 2006, 14, 3106-3112.